Scientific Data and Presentations

Newly published studies project the clinical impact of the Cap-Score™ by improving pregnancy rates and saving couples time and money.

Babigumira, J.B., Sharara, F.I. & Garrison, L.P. Projecting the potential impact of the Cap-Score™ on clinical pregnancy, live births, and medical costs in couples with unexplained infertility. J Assist Reprod Genet (2017).

Newly published studies validate the clinical utility of the Cap-Score™ Sperm Function Test.

Cardona CNeri QVSimpson AJ, et al. Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measuresMol Reprod Dev201784:423435. 

Moody MACardona CSimpson AJSmith TTTravis AJOstermeier GCValidation of a laboratory-developed test of human sperm capacitationMol Reprod Dev201784:408422.

Androvia LifeSciences will have a presence at the following scientific meetings in 2017:

ASRM: American Society of Reproductive Medicine
October 28-November 1, 2017; San Antonio, TX
Booth # 407.

Below are details from past meetings and presentations:

ASA: American Society of Andrology
April 22-25, 2017; Miami, FL
Exhibited and presented one study.

  • Abstract #P-136Localization patterns of the ganglioside GM1 identify sperm capable of undergoing capacitation and acrosome exocytosis
    Poster session: Monday, April 24th @ 11:15am-12:30pm

ASRM: American Society of Reproductive Medicine
October 15-19, 2016; Salt Lake City, UT
Booth # 323 and presented two studies.

  • Abstract #P-354: Capacitation defects are common in men questioning their fertility and are independent of standard semen analysis parameters
    Poster Session: Tuesday, October 18th @ 7:00am-8:45am
  • Abstract #P-523: Capacitation timing varies among men, but is consistent among ejaculates within individuals
    Poster Session: Wednesday, October 19th @ 7:00am-8:45am

AUA: American Urological Association + SSMR Annual Meeting: Society for the Study of Male Reproduction
May 6-10, 2016; San Diego, CA
Booth # 4152 and presented one study.

  • Abstract #MP70-10: Impacts of common semen handling methods on sperm function
    Poster Session: Monday, May 9th @ 10:30am-12:30pm

ASA: American Society of Andrology
April 2-5, 2016; New Orleans, LA
Exhibited and presented four studies.

  • Abstract #12: Consistent differences among men in capacitation timing could personalize IUI/ART
    Oral Presentation: Sunday, April 3rd @ 3:15pm
    Poster Session: Sunday, April 3rd @ 11:00am-12:30pm
  • Abstract #138: Normal ejaculates, as defined by WHO, can have abnormal capacitation ability
    Poster Session: Monday, April 4th @ 11:15am-12:30pm
  • Abstract #140: Sperm from fertile men and those seeking fertility exams differ in their ability to capacitate
    Poster Session: Monday, April 4th @ 11:15am-12:30pm
  • Abstract #137: Reliability estimates for a test of sperm capacitation, a functional complement to semen analysis
    Poster Session: Monday, April 4th @ 11:15am-12:30pm

# # #

A New Test for Male Infertility is on the Horizon: The Androvia Cap-Score

Male Fertility Doc, January 27, 2016
Coming soon, a company named Androvia will be releasing a new test that assesses the fertilizing ability of a man’s sperm.  Prior to fertilization, an individual sperm must complete three tasks: “capacitation”, “hyperactivation” and the “acrosome reaction”.  Androvia uses technology that identifies the ability of sperm to undergo capacitation.